- 1101. Request patient authorization
- (UMLS (HL7) C1548103) =Idea or Concept =Message type;
| - 1151. Resectable Mass
- (UMLS (NCI) C1335759) =Finding ;
|
- 1102. Request patient demographics
- (UMLS (HL7) C1548106) =Idea or Concept =Message type;
| - 1152. Resected Mass
- (UMLS (NCI) C1335760) =Finding ;
|
- 1103. Request patient information
- (UMLS (HL7) C1548105) =Idea or Concept =Message type;
| - 1153. Resection of Clavicle
- [Surgical removal of part or all of the clavicle. ( NCI )] (UMLS (NCI) C0186434) =Therapeutic or Preventive Procedure
|
- 1104. Request received
- (UMLS (HL7) C1548257) =Intellectual Product =Order control codes;
| - 1154. RESECTION OF NOSE
- (UMLS (ICD9CM) C0176364) =Therapeutic or Preventive Procedure
|
- 1105. Request to dispense blood product
- (UMLS (HL7) C1548991) =Idea or Concept =Blood Product Dispense Status;
| - 1155. Resection of other thoracic vessels with anastomosis
- [ ] (UMLS (ICD9CM) C0176637) =Therapeutic or Preventive Procedure
|
- 1106. Request to Restrict Access/Disclosure to Medical Record/Protected Health Information
- (UMLS (HL7) C1548912) =Health Care Activity =Consent Type;
| - 1156. Resection of Terminal Ileum
- [Surgical removal of part or all of the terminal portion of the ileum. ( NCI )] (UMLS (NCI) C0585098) =Therapeutic or Preventive Procedure
|
- 1107. Requested information
- (UMLS (HL7) C1546925) =Temporal Concept =Report timing;
| - 1157. Resection of transverse colon
- [Surgical removal of the transverse colon. ( NCI )] (UMLS (ICD9CM) C0192863) =Therapeutic or Preventive Procedure
|
- 1108. Required
- (UMLS (HL7) C1556066) =Idea or Concept =Escort Required;
| - 1158. Resection of vessel with anastomosis
- [ ] (UMLS (ICD9CM) C0189606) =Therapeutic or Preventive Procedure
|
- 1109. required
- [A signature for the service is required of this actor. ( HL7V3.0 )] (UMLS (HL7) C1546857) =Intellectual Product =ParticipationSignature;
| - 1159. Resection of vessel with replacement
- (UMLS (ICD9CM) C0189617) =Therapeutic or Preventive Procedure
|
- 1110. Required
- [The message element must appear every time the message is communicated, but the value may be communicated as null. ( HL7V3.0 )] (UMLS (HL7) C1619636) =Intellectual Product =InclusionNotMandatory;
| - 1160. Resection of vessel with replacement, unspecified site
- [ ] (UMLS (ICD9CM) C0375951) =Therapeutic or Preventive Procedure
|
- 1111. Required association missing
- [Required association missing in message; or the sequence of the classes is different than required by the standard or one of the conformance profiles identified in the message. ( HL7V3.0 )] (UMLS (HL7) C1699005) =Functional Concept =AcknowledgementDetailSyntaxErrorCode;
| - 1161. reserpate derivative
- [ ] (UMLS (CSP) C0599314) =Organic Chemical; Pharmacologic Substance
|
- 1112. Required attribute missing
- [A required attribute is missing in a class. ( HL7V3.0 )] (UMLS (HL7) C1696162) =Functional Concept =AcknowledgementDetailSyntaxErrorCode;
| - 1162. Reserved (ordered and product allocated for the patient)
- (UMLS (HL7) C1548992) =Idea or Concept =Blood Product Dispense Status;
|
- 1113. Required field missing
- (UMLS (HL7) C1549937) =Intellectual Product =Message error condition codes;
| - 1163. Reserved and ready to dispense
- (UMLS (HL7) C1548987) =Idea or Concept =Blood Product Dispense Status;
|
- 1114. Required intervention to prevent permanent impairment/damage
- (UMLS (HL7) C1546955) =Idea or Concept =Event Consequence;
| - 1164. Reserved for future HL7 registration schemes
- (UMLS (HL7) C1548520) =Intellectual Product =Universal ID type;
|
- 1115. Required may be empty
- [Pursuant to a profile or vendor conformance claim, the message element must appear every time the message is communicated, but the value may be communicated as null. ( HL7V3.0 )] (UMLS (HL7) C1554076) =Idea or Concept =Not required;
| - 1165. Reserved for future use
- (UMLS (HL7) C1548957) =Idea or Concept =Sequence/Results Flag;
|
- 1116. Requires crib
- [A crib is required to move the person ( HL7V3.0 )] (UMLS (HL7) C1553395) =Idea or Concept =Mobility impaired;
| - 1166. Reserved for possible future use
- (UMLS (HL7) C1549033) =Idea or Concept =Sequence condition;
|
- 1117. Requires crutches
- [Person requires crutches to ambulate ( HL7V3.0 )] (UMLS (HL7) C1553391) =Finding =Mobility impaired;
| - 1167. RESERVED _ do not use
- (UMLS (HL7) C1548500) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
|
- 1118. Requires gurney
- [A gurney is required to move the person ( HL7V3.0 )] (UMLS (HL7) C1553394) =Idea or Concept =Mobility impaired;
| - 1168. Residence
- [Any address at which a person dwells more than temporarily. ( NCI )] (UMLS (NCI) C0237096) =Spatial Concept ;
|
- 1119. Requires walker
- [Person requires a walker to ambulate ( HL7V3.0 )] (UMLS (HL7) C1553392) =Idea or Concept =Mobility impaired;
| - 1169. Residence at birth (home address at time of birth)
- (UMLS (HL7) C1549629) =Idea or Concept =Address type;
|
- 1120. Requires wheelchair
- [Person requires a wheelchair to be ambulatory ( HL7V3.0 )] (UMLS (HL7) C1553393) =Idea or Concept =Mobility impaired;
| - 1170. Resident
- (UMLS (HL7) C1549439) =Intellectual Product =Procedure Practitioner Identifier Code Type;
|
- 1121. RER
- (UMLS (HL7) C1549889) =Intellectual Product =Message structure;
| - 1171. Resident
- [A physician who has completed medical school and an internship and is in the process of receiving specialised training. ( NCI )] (UMLS (NCI) C1320928) =Professional or Occupational Group
|
- 1122. RER - Pharmacy/treatment encoded order information
- (UMLS (HL7) C1549327) =Health Care Activity =Event Type;
| - 1172. residential care facility
- [facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required, generally for those not needing hospital services but still in need of medical assistance. ( CSP )] (UMLS (CSP) C0237680) =Manufactured Object; Health Care Related Organization =Health Care Facility;
=home for elderly |
- 1123. Rerun Dilution
- [The value of the dilution of a sample after it had been analyzed at a prior dilution value ( HL7V3.0 )] (UMLS (HL7) C1551348) =Intellectual Product =ActSpecObsDilutionCode;
| - 1173. residential mobility
- [change of residence, either in the same city or town, or between cities, states or communities. ( CSP )] (UMLS (CSP) C0035187) =Activity ;
=social mobility;
|
- 1124. Rescinded _ Consent was initially granted, but was subsequently revoked or ended.
- (UMLS (HL7) C1548947) =Idea or Concept =Consent Status;
| - 1174. Residential Treatment Facilities
- [Live in facilities where patients or clients, who because of their physical, mental, or emotional condition, are not able to live independently, and who receive treatment appropriate to their particular needs in a less restrictive environment than an inpatient facility. For example, an RTC may provide educational training and therapy for children with emotional disturbances or continuing care and therapy for people with severe mental handicaps. ( HL7V3.0 )] (UMLS (HL7) C1552486) =Intellectual Product ;
=NUCC Health Care Provider Taxonomy;
=Psychiatric Residential Treatment Facility;
Residential Treatment Facility, Emotionally Disturbed Children;
Substance Use Disorder Rehabilitation Facility;
Community Based Residential Treatment Facility, Mental Illness;
Community Based Residential Treatment Facility, Mental Retardation and/or Developmental Disabilities;
Residential Treatment Facility, Mental Retardation and/or Developmental Disabilities;
Residential Treatment Facility, Physical Disabilities |
- 1125. RESCINNAMINE
- (UMLS (NCI) C0035167) =Organic Chemical; Pharmacologic Substance =(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic Acid Methyl Ester;
[CV490] ANTIHYPERTENSIVES, OTHER | - 1175. Residential Treatment Facilities; Psychiatric Residential Treatment Facility
- [A residential treatment center (RTC) is a facility or distinct part of a facility that providers, to children and adolescents, a total, twenty-four hour, therapeutically planned group living and learning situation where distinct and individualized psychotherapeutic interventions can take place. residential treatment is a specific level of care to e differentiated from acute, intermediate, and long-term hospital care, when the least restrictive environment is maintained to allow for normalization of the patient's surroundings. The RTC must be both physically and programmatically distinct if it is a part or subunit of a larger treatment program. A RTC is organized and professionally staffed to provide residential treatment of mental disorders to children and adolescents who have sufficient intellectual potential to respond to active treatment (that is , for whom it can reasonably be assumed that treatment of the mental disorder will result in an improved ability to function outside the RTC) for whom outpatient treatment, partial hospitalization or protected and structured environment is medically or psychologically necessary. ( HL7V3.0 )] (UMLS (HL7) C1551314) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
|
- 1126. Rescriptor
- (UMLS (NCI) C0699884) =Organic Chemical; Pharmacologic Substance
| - 1176. Residential Treatment Facilities; Residential Treatment Facility for Emotionally Disturbed Children
- [A provider facility or distinct part of the organization which renders an interdisciplinary program of mental health treatment to individuals under 21 years of age who have persistent dysfunction in major life areas. The dysfunction is of an extent and pervasiveness that requires a protected and highly structured therapeutic environment. These organizations, or distinct part of organizations, exclude those that provide acute psychiatric care, partial hospitalization, group living, therapeutic schooling, primary diagnosis substance abuse disorder treatment, or primary diagnosis mental retardation or developmental disability treatment. ( HL7V3.0 )] (UMLS (HL7) C1551315) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
|
- 1127. Research
- (UMLS (HL7) C1548287) =Idea or Concept =Charge type;
| - 1177. Residential Treatment Facilities; Substance Use Rehabilitation Facility
- [(X12N 324500000N) ( HL7V3.0 )] (UMLS (HL7) C1550692) Substance use rehabilitation facility;
=Intellectual Product =Residential treatment facility;
HealthcareProviderTaxonomyHIPAA |
- 1128. Research
- (UMLS (HL7) C1552456) =Manufactured Object; Health Care Related Organization =Clinic/Center;
| - 1178. Residential treatment facility
- (UMLS (HL7) C1550691) =Intellectual Product =DedicatedClinicalLocationRoleType;
=Residential Treatment Facilities; Substance Use Rehabilitation Facility;
Pain rehabilitation center;
|
- 1129. Research
- [Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered. ( NCI )] (UMLS (NCI) C0242481) =Research Activity ;
| - 1179. Residential Treatment Facility, Emotionally Disturbed Children
- [A provider facility or distinct part of the organization which renders an interdisciplinary program of mental health treatment to individuals under 21 years of age who have persistent dysfunction in major life areas. The dysfunction is of an extent and pervasiveness that requires a protected and highly structured therapeutic environment. These organizations, or distinct part of organizations, exclude those that provide acute psychiatric care, partial hospitalization, group living, therapeutic schooling, primary diagnosis substance abuse disorder treatment, or primary diagnosis mental retardation or developmental disability treatment.Source: U.S. Department of Defense Regulation 6010.8-R, Chapter 6. ( HL7V3.0 )] (UMLS (HL7) C1552488) =Intellectual Product ;
=Residential Treatment Facilities;
|
- 1130. Research Data Abstracter/Coder
- (UMLS (HL7) C1556036) =Intellectual Product =Specialist;
| - 1180. Residential Treatment Facility, Mental Retardation and/or Developmental Disabilities
- [A residential facility that provides habilitation services and other care and treatment to adults or children diagnosed with developmental disabilities and/or mental retardation and are not able to live independently. ( HL7V3.0 )] (UMLS (HL7) C1552543) =Intellectual Product ;
=Residential Treatment Facilities;
|
- 1131. research data dissemination
- [ ] (UMLS (CSP) C1328946) =Research Activity ;
| - 1181. Residential Treatment Facility, Physical Disabilities
- [A residential facility that provides habilitation services and other care and treatment to adults or children diagnosed with developmental disabilities and/or mental retardation and are not able to live independently. ( HL7V3.0 )] (UMLS (HL7) C1552544) =Intellectual Product ;
=Residential Treatment Facilities;
|
- 1132. Research Ethics
- [The branch of ethics that studies moral values in research sciences and practices. ( NCI )] (UMLS (NCI) C0814851) =Idea or Concept
| - 1182. RESIDUAL ANGL-CLOS GLAUC
- [ ] (UMLS (ICD9CM) C0154948) =Disease or Syndrome ;
|
- 1133. Research Facilities
- [The buildings, equipment and staff of a research group ( NCI )] (UMLS (NCI) C0598009) =Manufactured Object ;
| - 1183. residual cancer
- [ ] (UMLS (CSP) C0242594) =Neoplastic Process ;
|
- 1134. Research Methods
- [Develop and evaluate new laboratory assays, behavioral methods, and statistical techniques for epidemiologic studies. (FMB) ( NCI )] (UMLS (NCI) C0086912) =Research Activity ;
| - 1184. Residual Chronic Schizophrenia
- (UMLS (NCI) C0270408) =Mental or Behavioral Dysfunction
|
- 1135. Research Nurse
- [A nurse who is involved in the treatment and observation of patients as part of a systematic investigation. ( NCI )] (UMLS (NCI) C0687693) =Professional or Occupational Group
| - 1185. residual disease
- [Cancer cells that remain after attempts to remove the cancer have been made. ( NCI )] (UMLS (NCI) C0543478) =Neoplastic Process ;
|
- 1136. Research Resource
- [The funding, research facilities, and materials available for research ( NCI )] (UMLS (NCI) C0035201) =Idea or Concept ;
| - 1186. RESIDUAL HEMORRHOID TAGS
- [ ] (UMLS (ICD9CM) C0155788) =Anatomical Abnormality ;
|
- 1137. Research Specimen
- [A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis. ( NCI )] (UMLS (NCI) C0370003) =Substance ;
| - 1187. RESIDUAL OPN ANG GLAUCMA
- [ ] (UMLS (ICD9CM) C0154944) =Disease or Syndrome ;
|
- 1138. Research Study
- (UMLS (HL7) C1556037) =Professional or Occupational Group =Specialist;
| - 1188. Residual schizophrenia, chronic state with acute exacerbation
- [ ] (UMLS (ICD9CM) C0154373) =Mental or Behavioral Dysfunction
|
- 1139. research subject
- [ Definition:Specifies the administrative functionality within a formal experimental design for which the ResearchSubject role was established. Examples: Screening - role is used for pre-enrollment evaluation portion of the design; enrolled - role is used for subjects admitted to the experimental portion of the design. ( HL7V3.0 )] (UMLS (HL7) C0080105) =Population Group ;
=Investigation Subject;
| - 1189. Residual schizophrenia, in remission
- [ ] (UMLS (ICD9CM) C0154374) =Mental or Behavioral Dysfunction
|
- 1140. Research Support
- [This includes all types of grants, cooperative agreements, and research contracts that support research directly and for which individuals and/or projects have been peer-reviewed. ( NCI )] (UMLS (NCI) C0035176) =Quantitative Concept ;
| - 1190. Residual schizophrenia, subchronic state
- [ ] (UMLS (ICD9CM) C0270406) =Mental or Behavioral Dysfunction
|
- 1141. Research Technique
- [Technique used in the laboratory for scientific research. ( NCI )] (UMLS (NCI) C0035177) =Research Activity ;
| - 1191. Residual schizophrenia, subchronic state with acute exacerbation
- [ ] (UMLS (ICD9CM) C0154372) =Mental or Behavioral Dysfunction
|
- 1142. ResearchSubjectRoleBasis
- [Specifies the administrative functionality within a formal experimental design for which the ResearchSubject role was established. Examples: screening - role is used for pre-enrollment evaluation portion of the design; enrolled - role is used for subjects admitted to the active treatment portion of the design. ( HL7V3.0 )] (UMLS (HL7) C1698905) =Intellectual Product =RoleCode;
| - 1192. Residual schizophrenia, unspecified state
- (UMLS (ICD9CM) C0036351) =Mental or Behavioral Dysfunction
|
- 1143. RESECT ABDM AORTA W REPL
- [ ] (UMLS (ICD9CM) C0190338) =Therapeutic or Preventive Procedure
| - 1193. Resighini Rancheria, California (formerly known as
- (UMLS (HL7) C1554458) =Population Group =NativeEntityContiguous;
|
- 1144. RESECT EXT SEG LG BOWEL
- (UMLS (ICD9CM) C0192837) =Therapeutic or Preventive Procedure
| - 1194. resin
- [polymers of high molecular weight which at some stage are capable of being molded and then hardened to form useful components; includes plant resins, oxidation or polymerization products of terpenes. ( CSP )] (UMLS (CSP) C0035191) =Organic Chemical; Pharmacologic Substance =Biomedical and Dental Materials;
Material =composite resin;
Balsams;
rosin;
shellac;
|
- 1145. RESECT EXT SEG SM BOWEL
- [ ] (UMLS (ICD9CM) C0192620) =Therapeutic or Preventive Procedure
| - 1195. Resiniferatoxin
- [A capsaicin ( NCI )] (UMLS (NCI) C0073081) =Organic Chemical; Pharmacologic Substance ;
|
- 1146. RESECT THORAC VES W REPL
- [ ] (UMLS (ICD9CM) C0176642) =Therapeutic or Preventive Procedure
| - 1196. resistance (electrical)
- [ ] (UMLS (CSP) C0162535) =Natural Phenomenon or Process
|
- 1147. Resectable Carcinoma of Small Bowel
- [Carcinoma of the small intestine amendable to resection. ( NCI )] (UMLS (NCI) C0854789) Resectable Carcinoma of Small Intestine;
Resectable Carcinoma of the Small Bowel;
Resectable Carcinoma of the Small Intestine;
Resectable Small Bowel Carcinoma;
Resectable Small Intestinal Cancer;
Resectable Small Intestine Carcinoma;
Small Intestine Carcinoma, Resectable;
=Neoplastic Process | - 1197. Resistant. Indicates for microbiology susceptibilities only.
- (UMLS (HL7) C1548141) =Qualitative Concept =Abnormal flags;
|
- 1148. Resectable Cholangiocarcinoma
- (UMLS (NCI) C0862981) Resectable Cholangiocellular Carcinoma =Neoplastic Process
| - 1198. resistent
- [Resistent ( HL7V3.0 )] (UMLS (HL7) C1550464) =Idea or Concept =ObservationInterpretationSusceptibility;
|
- 1149. Resectable Duodenal Carcinoma
- (UMLS (NCI) C0861843) =Neoplastic Process
| - 1199. RESISTIVE EXERCISE
- (UMLS (ICD9CM) C0203991) =Therapeutic or Preventive Procedure
|
- 1150. Resectable Hepatic Malignant Neoplasm
- (UMLS (NCI) C0854795) Resectable Malignant Neoplasm of Liver;
=Neoplastic Process | - 1200. RESOLV IDIOPATH SCOLIOS
- [ ] (UMLS (ICD9CM) C0158502) =Acquired Abnormality; Disease or Syndrome
|
home
